Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission

S. Bautista-Arredondo, S. Sosa-Rubí, M. Opuni, D. Contreras-Loya, A. Kwan, C. Chaumont, A. Chompolola, J. Condo, O. Galárraga, N. Martinson, F. Masiye, S. Nsanzimana, I. Ochoa‐Moreno, R. Wamai, J. Wang'ombe
{"title":"Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission","authors":"S. Bautista-Arredondo, S. Sosa-Rubí, M. Opuni, D. Contreras-Loya, A. Kwan, C. Chaumont, A. Chompolola, J. Condo, O. Galárraga, N. Martinson, F. Masiye, S. Nsanzimana, I. Ochoa‐Moreno, R. Wamai, J. Wang'ombe","doi":"10.1097/QAD.0000000000001208","DOIUrl":null,"url":null,"abstract":"Objective:We estimate facility-level average annual costs per client along the HIV testing and counselling (HTC) and prevention of mother-to-child transmission (PMTCT) service cascades. Design:Data collected covered the period 2011–2012 in 230 HTC and 212 PMTCT facilities in Kenya, Rwanda, South Africa, and Zambia. Methods:Input quantities and unit prices were collected, as were output data. Annual economic costs were estimated from the service providers’ perspective using micro-costing. Average annual costs per client in 2013 United States dollars (US$) were estimated along the service cascades. Results:For HTC, average cost per client tested ranged from US$5 (SD US$7) in Rwanda to US$31 (SD US$24) in South Africa, whereas average cost per client diagnosed as HIV-positive ranged from US$122 (SD US$119) in Zambia to US$1367 (SD US$2093) in Rwanda. For PMTCT, average cost per client tested ranged from US$18 (SD US$20) in Rwanda to US$89 (SD US$56) in South Africa; average cost per client diagnosed as HIV-positive ranged from US$567 (SD US$417) in Zambia to US$2021 (SD US$3210) in Rwanda; average cost per client on antiretroviral prophylaxis ranged from US$704 (SD US$610) in South Africa to US$2314 (SD US$3204) in Rwanda; and average cost per infant on nevirapine ranged from US$888 (SD US$884) in South Africa to US$2359 (SD US$3257) in Rwanda. Conclusion:We found important differences in unit costs along the HTC and PMTCT service cascades within and between countries suggesting that more efficient delivery of these services is possible.","PeriodicalId":355297,"journal":{"name":"AIDS (London, England)","volume":"79 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"28","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000001208","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 28

Abstract

Objective:We estimate facility-level average annual costs per client along the HIV testing and counselling (HTC) and prevention of mother-to-child transmission (PMTCT) service cascades. Design:Data collected covered the period 2011–2012 in 230 HTC and 212 PMTCT facilities in Kenya, Rwanda, South Africa, and Zambia. Methods:Input quantities and unit prices were collected, as were output data. Annual economic costs were estimated from the service providers’ perspective using micro-costing. Average annual costs per client in 2013 United States dollars (US$) were estimated along the service cascades. Results:For HTC, average cost per client tested ranged from US$5 (SD US$7) in Rwanda to US$31 (SD US$24) in South Africa, whereas average cost per client diagnosed as HIV-positive ranged from US$122 (SD US$119) in Zambia to US$1367 (SD US$2093) in Rwanda. For PMTCT, average cost per client tested ranged from US$18 (SD US$20) in Rwanda to US$89 (SD US$56) in South Africa; average cost per client diagnosed as HIV-positive ranged from US$567 (SD US$417) in Zambia to US$2021 (SD US$3210) in Rwanda; average cost per client on antiretroviral prophylaxis ranged from US$704 (SD US$610) in South Africa to US$2314 (SD US$3204) in Rwanda; and average cost per infant on nevirapine ranged from US$888 (SD US$884) in South Africa to US$2359 (SD US$3257) in Rwanda. Conclusion:We found important differences in unit costs along the HTC and PMTCT service cascades within and between countries suggesting that more efficient delivery of these services is possible.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
艾滋病毒检测和咨询以及预防母婴传播的服务费用
目的:我们沿HIV检测和咨询(HTC)和预防母婴传播(PMTCT)服务级联估计每个客户的设施水平平均年成本。设计:收集的数据涵盖2011-2012年期间在肯尼亚、卢旺达、南非和赞比亚的230个HTC和212个预防母婴传播设施。方法:收集投入数量、单价及产出数据。使用微观成本法从服务提供者的角度估计了年度经济成本。按服务级联估算了2013年每位客户的平均年成本(美元)。结果:对于HTC,每个检测客户的平均成本从卢旺达的5美元(SD $7)到南非的31美元(SD $24)不等,而每个诊断为艾滋病毒阳性的客户的平均成本从赞比亚的122美元(SD $119)到卢旺达的1367美元(SD $2093)不等。对于预防母婴传播,每个检测对象的平均成本从卢旺达的18美元(20美元)到南非的89美元(56美元)不等;每名被诊断为艾滋病毒阳性的患者的平均费用从赞比亚的567美元(417美元)到卢旺达的2021美元(3210美元)不等;抗逆转录病毒预防每位患者的平均费用从南非的704美元(610 SD美元)到卢旺达的2314美元(3204 SD美元)不等;奈韦拉平每名婴儿的平均费用从南非的888美元(884瑞典克朗)到卢旺达的2359美元(3257瑞典克朗)不等。结论:我们发现,在国家内部和国家之间,沿着HTC和PMTCT服务级联的单位成本存在重大差异,这表明更有效地提供这些服务是可能的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Primary HIV infection during chronic treatment with imatinib: impact on infection dynamics Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves Vespers: A nursing origin story set in the dawn of the HIV pandemic Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV Glottic Kaposi's sarcoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1